The content on or accessible through Medpedia.com is for informational purposes only. Medpedia is not a substitute for professional advice or expert medical services from a qualified health professional. Read more

Parkinson disease (autosomal recessive, juvenile) 2, parkin gene (PARK2)

Lead Editors

(Become a Lead Editor)

There are currently no Lead Editors of this article.

Ask a Question on This Topic

Important Resources for Parkinson disease (autosomal recessive, juvenile) 2, parkin gene (PARK2):

There is 1 user following this page.

The information on this page is seed content provided by an organization. Please help improve this Article by adding to it. If you are a physician or PhD, learn how to edit. If you are anyone else, learn how to suggest changes.


The official name of this gene is “Parkinson disease (autosomal recessive, juvenile) 2, parkin.”

PARK2 is the gene's official symbol. The PARK2 gene is also known by other names, listed below.


Contents

What is the normal function of the PARK2 gene?

The PARK2 gene, one of the largest human genes, provides instructions for making a protein called parkin. Parkin plays a role in the cell machinery that breaks down (degrades) unwanted proteins by tagging damaged and excess proteins with molecules called ubiquitin. Ubiquitin serves as a signal to move unwanted proteins into specialized cell structures known as proteasomes, where the proteins are degraded. The ubiquitin-proteasome system acts as the cell's quality control system by disposing of damaged, misshapen, and excess proteins. This system also regulates the level of proteins involved in several critical cell activities such as the timing of cell division and growth. Because of its activity in the ubiquitin-proteasome system, parkin belongs to a protein group called E3 protein-ubiquitin ligases.

Studies of the structure and activity of parkin have led researchers to suggest other activities for this protein. Parkin may act as a tumor suppressor protein, which means it prevents cells from growing and dividing too rapidly or in an uncontrolled way. Parkin may also regulate the supply and release of sacs, called synaptic vesicles, from nerve cells. Synaptic vesicles contain chemical messengers that transmit signals from one nerve cell to another.


How are changes in the PARK2 gene related to health conditions?

Parkinson disease - caused by mutations in the PARK2 gene

Researchers have identified more than 100 PARK2 mutations that cause juvenile Parkinson disease and some adult-onset cases. Some mutations lead to an abnormally small parkin protein, which is nonfunctional and degrades rapidly. Other mutations change the building blocks (amino acids) used to make parkin, and the altered protein cannot function properly. PARK2 mutations usually lead to a loss of parkin activity.

It is not clearly understood how PARK2 mutations cause Parkinson disease. The loss of parkin activity probably disturbs the ubiquitin-proteasome system, which allows unwanted proteins to accumulate. Accumulated proteins could disrupt normal cell activities such as the supply and release of synaptic vesicles, particularly those that contain a chemical messenger called dopamine. As parkin is normally abundant in the brain, its loss could lead to the impairment or death of nerve cells, including those that produce dopamine. Loss of dopamine-producing nerve cells is a characteristic feature of Parkinson disease.

cancers - associated with the PARK2 gene

The PARK2 gene spans part of a fragile area (known as FRA6E) on chromosome 6. This fragile area is unstable and prone to breakage and rearrangement. In tumors from some patients with ovarian or lung cancer, segments of the PARK2 gene within the FRA6E region are deleted or duplicated. As a result of these alterations, parkin activity is absent or reduced. These findings suggest that the PARK2 gene normally acts as a tumor suppressor gene, by restraining cell division and growth. If it is altered, cells can grow and divide in an uncontrolled manner, leading to a tumor.

other disorders - increased risk from variations of the PARK2 gene

Recent studies suggest that normal variations (polymorphisms) in the PARK2 gene (and a neighboring gene called PACRG) can increase the risk of contracting leprosy. Leprosy is a disease that affects the nerves and skin and is caused by the bacterium Mycobacterium leprae. It remains unclear how PARK2 polymorphisms increase leprosy susceptibility. Researchers believe that the ubiquitin-proteasome system may play a role in controlling infection. PARK2 polymorphisms may slightly alter parkin's function, making the ubiquitin-proteasome system less efficient.


Where is the PARK2 gene located?

Cytogenetic Location: 6q25.2-q27 Molecular Location on chromosome 6: base pairs 161,689,660 to 163,068,792

[[Image:Image:Http://ghr.nlm.nih.gov/dynamicImages/chromomap/park2.jpeg]]

The PARK2 gene is located on the long (q) arm of chromosome 6 between positions 25.2 and 27. More precisely, the PARK2 gene is located from base pair 161,689,660 to base pair 163,068,792 on chromosome 6. See How do geneticists indicate the location of a gene? (http://ghr.nlm.nih.gov/​handbook/​howgeneswork/​genelocation) in the Handbook.

What other names do people use for the PARK2 gene or gene products?

  • AR-JP
  • parkin
  • PDJ
  • PRKN
  • PRKN2_HUMAN
  • ubiquitin E3 ligase


External Links

Where can I find additional information about PARK2?

You and your healthcare professional may find the following resources about PARK2 helpful.

  • Educational resources - Information pages 
Annual Reviews Collection, National Center for Biotechnology Information: Overview of the Ubiquitin-Proteasome Degradation System (http://www.ncbi.nlm.nih.gov/​bookshelf/​br.fcgi?​book=​arev&​part=​A98#​A103)
Biochemistry (fifth edition, 2002): Protein Turnover is Tightly Regulated (http://www.ncbi.nlm.nih.gov/​books/​bv.fcgi?​call=​    bv.View..ShowSection&​rid=​stryer.section.3200)
The Cell: A Molecular Approach (second edition, 2000): The Ubiquitin-Proteasome Pathway (http://www.ncbi.nlm.nih.gov/​books/​bv.fcgi?​rid=​cooper.section.1232#​1233)

You may also be interested in these resources, which are designed for genetics professionals and researchers. 

OMIM: parkin and fragile site FRA6E (http://www.ncbi.nlm.nih.gov/​entrez/​dispomim.cgi?​id=​602544)
OMIM: susceptibility to leprosy (http://www.ncbi.nlm.nih.gov/​entrez/​dispomim.cgi?​id=​607572)
  • Research Resources - Tools for researchers 
Atlas of Genetics and Cytogenetics in Oncology and Haematology (http://atlasgeneticsoncology.org/​Genes/​GC_​PARK2.html)
Entrez Gene (http://view.ncbi.nlm.nih.gov/​gene/​5071)
GeneCards (http://www.genecards.org/​cgi-​bin/​carddisp.pl?​gene=​PARK2)
HUGO Gene Nomenclature Committee (http://www.genenames.org/​data/​hgnc_​data.php?​hgnc_​id=​8607)

See How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/​handbook/​mutationsanddisorders/​naming) in the Handbook.


What glossary definitions help with understanding PARK2?

acids ; amino acid ; autosomal ; autosomal recessive ; bacteria ; cancer ; cell ; cell division ; chromosome ; dopamine ; gene ; infection ; juvenile ; ligase ; molecule ; mutation ; mycobacterium ; nerve cell ; ovarian ; polymorphism ; proteasome ; protein ; rearrangement ; recessive ; susceptibility ; synaptic vesicles ; tumor ; tumor suppressor gene ; ubiquitin ; vesicle You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://ghr.nlm.nih.gov/glossary).


References

Cookson MR. The biochemistry of Parkinson's disease. Annu Rev Biochem. 2005;74:29-52. Review. (http://www.ncbi.nlm.nih.gov/​entrez/​query.fcgi?​cmd=​retrieve&​db=​pubmed&​dopt=​Abstract&​list_​uids=​15952880)

Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A. Genetics of Parkinson's disease and parkinsonism. Ann Neurol. 2006 Oct;60(4):389-98. Review. (http://www.ncbi.nlm.nih.gov/​entrez/​query.fcgi?​cmd=​retrieve&​db=​pubmed&​dopt=​Abstract&​list_​uids=​17068789) Lim KL, Dawson VL, Dawson TM. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects. Ann N Y Acad Sci. 2003 Jun;991:80-92. Review. (http://www.ncbi.nlm.nih.gov/​entrez/​query.fcgi?​cmd=​retrieve&​db=​pubmed&​dopt=​Abstract&​list_​uids=​12846976)

Pankratz N, Foroud T. Genetics of Parkinson Disease. Neurorx. 2004 Apr;1(2):235-242. (http://www.ncbi.nlm.nih.gov/​entrez/​query.fcgi?​cmd=​retrieve&​db=​pubmed&​dopt=​Abstract&​list_​uids=​15717024)

To suggest changes to this page, you must create an account on Medpedia.

The content on or accessible through Medpedia.com is for informational purposes only. Medpedia is not a substitute for professional advice or expert medical services from a qualified health professional. Read more

See Also